Du Y, Cooper H
Chem Commun (Camb). 2025; 61(21):4168-4171.
PMID: 39963858
PMC: 11833770.
DOI: 10.1039/d4cc03881a.
Elias-Lopez C, Munoz-Rosa M, Guzman-Puche J, Perez-Nadales E, Chicano-Galvez E, Martinez-Martinez L
Ann Clin Microbiol Antimicrob. 2024; 23(1):103.
PMID: 39581990
PMC: 11587576.
DOI: 10.1186/s12941-024-00761-9.
Nicoloff H, Hjort K, Andersson D, Wang H
Nat Commun. 2024; 15(1):3981.
PMID: 38730266
PMC: 11087502.
DOI: 10.1038/s41467-024-48233-0.
Kyung S, Lee J, Lee E, Hwang C, Yoo H
BMC Microbiol. 2023; 23(1):323.
PMID: 37924028
PMC: 10623767.
DOI: 10.1186/s12866-023-03074-7.
Fonseca E, Morgado S, Freitas F, Bighi N, Cipriano R, Vicente A
Mem Inst Oswaldo Cruz. 2023; 118:e230081.
PMID: 37909500
PMC: 10626633.
DOI: 10.1590/0074-02760230081.
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014-2018).
Gracia-Ahufinger I, Lopez-Gonzalez L, Vasallo F, Galar A, Siller M, Pitart C
Front Microbiol. 2023; 14:1247804.
PMID: 37744921
PMC: 10516297.
DOI: 10.3389/fmicb.2023.1247804.
Antibiotic-Loaded Gold Nanoparticles: A Nano-Arsenal against ESBL Producer-Resistant Pathogens.
Danish Rizvi S, Lila A, Moin A, Hussain T, Kamal M, Sonbol H
Pharmaceutics. 2023; 15(2).
PMID: 36839753
PMC: 9967522.
DOI: 10.3390/pharmaceutics15020430.
Nano-Conversion of Ineffective Cephalosporins into Potent One against Resistant Clinical Uro-Pathogens via Gold Nanoparticles.
Danish Rizvi S, Hussain T, Alshammari F, Sonbol H, Ahmad N, Faiyaz S
Nanomaterials (Basel). 2023; 13(3).
PMID: 36770436
PMC: 9919271.
DOI: 10.3390/nano13030475.
The Blood-Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults.
Haddad N, Carr M, Balian S, Lannin J, Kim Y, Toth C
Antibiotics (Basel). 2022; 11(12).
PMID: 36551500
PMC: 9774927.
DOI: 10.3390/antibiotics11121843.
Genome-wide association study of identifies variations linked to carbapenems resistance.
Pei N, Sun W, He J, Li Y, Chen X, Liang T
Front Microbiol. 2022; 13:997769.
PMID: 36386631
PMC: 9664935.
DOI: 10.3389/fmicb.2022.997769.
Cephalosporin translocation across enterobacterial OmpF and OmpC channels, a filter across the outer membrane.
Masi M, Vergalli J, Ghai I, Barba-Bon A, Schembri T, Nau W
Commun Biol. 2022; 5(1):1059.
PMID: 36198902
PMC: 9534850.
DOI: 10.1038/s42003-022-04035-y.
Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study.
Chabert P, Provoost J, Cohen S, Dupieux-Chabert C, Bitker L, Ferry T
Ann Intensive Care. 2022; 12(1):90.
PMID: 36175707
PMC: 9522958.
DOI: 10.1186/s13613-022-01059-9.
Increased Expression and Amplification of Contributes to Resistance to Ceftazidime/Avibactam in a Sequence Type 11 Carbapenem-Resistant Klebsiella pneumoniae Strain.
Li X, Zhang J, Yang C, Li J, Wang J, Huang W
Microbiol Spectr. 2022; 10(4):e0095522.
PMID: 35900090
PMC: 9430841.
DOI: 10.1128/spectrum.00955-22.
Survey on Carbapenem-Resistant Bacteria in Pigs at Slaughter and Comparison with Human Clinical Isolates in Italy.
Bonardi S, Cabassi C, Manfreda G, Parisi A, Fiaccadori E, Sabatino A
Antibiotics (Basel). 2022; 11(6).
PMID: 35740183
PMC: 9219774.
DOI: 10.3390/antibiotics11060777.
Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in Due to Narrow-Spectrum β-Lactamases as Well as Omp Mutation.
Yang F, Zhao Q, Wang L, Wu J, Jiang L, Sheng L
Pol J Microbiol. 2022; 71(2):251-256.
PMID: 35716168
PMC: 9252146.
DOI: 10.33073/pjm-2022-023.
Antibacterial Activity of Imipenem/Relebactam against Clinical Isolates in Japan.
Kurihara D, Matsumoto S, Kishi N, Ishii Y, Mori M
Microbiol Spectr. 2022; 10(2):e0223521.
PMID: 35416695
PMC: 9045147.
DOI: 10.1128/spectrum.02235-21.
In Vitro Synergism of Azithromycin Combination with Antibiotics against OXA-48-Producing Clinical Isolates.
Singkham-In U, Muhummudaree N, Chatsuwan T
Antibiotics (Basel). 2021; 10(12).
PMID: 34943763
PMC: 8698995.
DOI: 10.3390/antibiotics10121551.
Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics.
Foudraine D, Strepis N, Stingl C, Ten Kate M, Verbon A, Klaassen C
Sci Rep. 2021; 11(1):12472.
PMID: 34127720
PMC: 8203672.
DOI: 10.1038/s41598-021-91905-w.
Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics.
Klebba P, Newton S, Six D, Kumar A, Yang T, Nairn B
Chem Rev. 2021; 121(9):5193-5239.
PMID: 33724814
PMC: 8687107.
DOI: 10.1021/acs.chemrev.0c01005.
Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections.
Makharita R, El-Kholy I, Hetta H, Abdelaziz M, Hagagy F, Ahmed A
Infect Drug Resist. 2020; 13:3991-4002.
PMID: 33177849
PMC: 7649219.
DOI: 10.2147/IDR.S276975.